Clinical electrophysiology

Results: 279



#Item
221NFID CLINICAL UPDATES  Staphylococcus aureus Bacteremia and Endocarditis The Role of Device and Lead Extraction Bruce L. Wilkoff, MD*

NFID CLINICAL UPDATES Staphylococcus aureus Bacteremia and Endocarditis The Role of Device and Lead Extraction Bruce L. Wilkoff, MD*

Add to Reading List

Source URL: www.nfid.org

Language: English
222Clinical Center Masur Auditorium Map

Clinical Center Masur Auditorium Map

Add to Reading List

Source URL: www.ors.od.nih.gov

Language: English - Date: 2011-09-09 10:44:33
223Health Canada Question and Answer Document Regarding the ICH S7B and E14 Guidances

Health Canada Question and Answer Document Regarding the ICH S7B and E14 Guidances

Add to Reading List

Source URL: www.hc-sc.gc.ca

Language: English - Date: 2013-07-12 14:26:08
224E14: The Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs

E14: The Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs

Add to Reading List

Source URL: www.hc-sc.gc.ca

Language: English - Date: 2013-07-12 14:25:41
225S7B: The Non-Clinical Evaluation of the Potential for Delayed Ventricular Repolarization (QT Interval Prolongation) by Human Pharmaceuticals

S7B: The Non-Clinical Evaluation of the Potential for Delayed Ventricular Repolarization (QT Interval Prolongation) by Human Pharmaceuticals

Add to Reading List

Source URL: www.hc-sc.gc.ca

Language: English - Date: 2013-07-12 14:26:11
226FDA Panel Questions 1 Safety The primary safety endpoint, the complication-free rate at 180-days post-implant, was assessed in all patients with an attempted S-ICD System implant. The 95% lower confidence bound was 97.9%

FDA Panel Questions 1 Safety The primary safety endpoint, the complication-free rate at 180-days post-implant, was assessed in all patients with an attempted S-ICD System implant. The 95% lower confidence bound was 97.9%

Add to Reading List

Source URL: www.fda.gov

Language: English
227A letter from the CEO of Heart Rhythm Society, James H. Youngblood  As I reflect back on all that the Heart Rhythm Society (HRS) has achieved, year after year, I’m impressed by the significant progress we have made. In

A letter from the CEO of Heart Rhythm Society, James H. Youngblood As I reflect back on all that the Heart Rhythm Society (HRS) has achieved, year after year, I’m impressed by the significant progress we have made. In

Add to Reading List

Source URL: www.hrsonline.org

Language: English
228The Pulse of Accomplishment A summary of accomplishments in 2011 Our Mission To improve the care of patients by promoting research, education, and optimal health care policies and standards.

The Pulse of Accomplishment A summary of accomplishments in 2011 Our Mission To improve the care of patients by promoting research, education, and optimal health care policies and standards.

Add to Reading List

Source URL: www.hrsonline.org

Language: English
229Microsoft Word[removed]Section 5_Updated S-ICD Panel Pack Executive Summary_FINAL REDACTED

Microsoft Word[removed]Section 5_Updated S-ICD Panel Pack Executive Summary_FINAL REDACTED

Add to Reading List

Source URL: www.fda.gov

Language: English
230The Pulse of Accomplishment A summary of accomplishments in 2010 SM

The Pulse of Accomplishment A summary of accomplishments in 2010 SM

Add to Reading List

Source URL: www.hrsonline.org

Language: English